Top Drug Discovery and Development Solution Companies in APAC-2020
Pharma Tech Outlook
Home »Drug Discovery and Development » Top Drug Discovery and Development Solution Companies in APAC
Mayne Contract Services: Supporting Drug Development-From Concept to Commercialization
line

Top 10 Drug Discovery and Development Solution Companies in APAC - 2020

line

With several breakthrough drugs reaching their patient cliffs, pharmaceutical companies and their service providers are in the constant pursuit to make drug development a more efficient process. And in the aftermath of advanced technologies, target-based drugs that focus on the patient’s genetic composition have emerged as the most potent weapon to pharmaceutical organizations. Not only do target-based drugs have minimal side effects on the adjoining genes or molecular mechanisms in the patient, but they are also less time-consuming and highly efficient. Besides, the use of advanced techniques likes High Throughput Screening (HTS), Quantitative Structure Activity Relationships (QSAR), and more are resulting in precision drug designs. Also, modern research disciplines such as proteomics, genomics, metabolomics, chemogenomics, and others are improving the drug discovery process at an alarming rate.

In the wake of such drastic transitions, we have compiled this issue of Pharma Tech Outlook in order to assist organizations in the task of finding accomplished solution providers and consulting/services companies to help them navigate the drug discovery and development realm. In this edition, we have listed the top 10 drug discovery and development solution providers in APAC – 2020 and top 10 drug discovery and development consulting/services companies in APAC – 2020 to highlight the enterprises that can escalate the chances of your growth. Equipped with innovative technological capabilities, these enlisted solution providers and consulting/services companies are transforming the drug discovery and development paradigm at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the pharmaceutical sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s, “Top 10 Drug Discovery and Development Consulting/ Services Companies in APAC – 2020”

    Top Drug Discovery and Development Solution Companies in APAC

    Mayne Contract Services
    Read full profile →
    At present, Mayne Pharma’s single focus is on making medicines better. “Paired with technology on the edge of convention, we breed an attractive and progressive-thinking culture. This is evident in our approach to fresh ideas, and then a speedy implementation to market,” says Stefan Cross, President, International Operations at Mayne Pharma. The company has developed several oral drug delivery systems that have been successfully commercialized in numerous products like ASTRIX® to treat cardiovascular disease, DORYX® for acne and certain bacterial infections or as an anti-malarial, ERYC® that is used in the treatment of bacterial infections, KAPANOL® for the management of chronic breathlessness and chronic pain, and LOZANOC®/TOLSURA®, super-bioavailable itraconazole used to treat fungal infections ... read full profile
    Adagene
    Adagene, Inc. is a private, clinical-stage, leading-edge oncology immunotherapy company driven by its powerful Dynamic Precision Library platform built to deliver treatments with increased efficacy and safety. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs
    GenoFocus
    GenoFocus is a platform technology company developing enzyme solutions for specialty food, eco-friendly processes, biopharmaceuticals, cosmeceuticals and agriculture. The company develops custom-optimized enzymes through molecular evolution using smart library generation and microbial display-based high throughput screening. With fungal and bacterial secretion systems, GenoFocus custom produces the evolved enzymes through large-scale fermentation, then purify and formulate the enzyme products with sophisticated downstream processes
    Medlab Clinical
    Medlab Clinical Ltd has an outstanding research portfolio in early phase drug discovery across obesity, chronic kidney disease, depression, skeletal health and non-opioid pain management and is committed to producing products practitioners can rely on. The company fabricates remarkable pharmaceuticals that triumph against current market competition
    nan]i[on
    Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. The company's efficient and highly versatile products maximize the output in ion channel screening, safety testing and scientific research. The innovative nature of their products offers unparalleled experimental flexibility combined with a throughput allowing fast and accurate screening of compounds acting on ion channels
    On-chip Biotechnologies
    On-chip Biotechnologies, incorporated in 2005, is the first company in the world to launch a microfluidic chip-based cell sorter on the market. The company's microfluidic chip-based cell sorter, On-chip Sort, designed and manufactured in Japan, uses a disposable microfluidic chip as the core of its technology. On-chip Biotechnologies' microfluidic chips are manufactured with Japan’s outstanding high-precision plastic injection molding technology
    Rigaku
    Since its inception in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Today, with hundreds of major innovations to their credit, the Rigaku Group of Companies are world leaders in the fields of general X-ray diffraction (XRD), thin-film analysis (XRF, XRD and XRR), X-ray fluorescence spectrometry (TXRF, EDXRF and WDXRF), small angle X-ray scattering (SAXS), protein and small molecule X-ray crystallography, Raman spectroscopy, X-ray optics, semiconductor metrology (TXRF, XRF, XRD and XRR), X-ray sources, computed tomography, nondestructive testing and thermal analysis
    Sartorius
    Sartorius is a leading international partner of life sciences and the biopharmaceutical industry. In their ambition to simplify progress for customers across the globe, the company provides them with innovative technologies that help them develop and manufacture medications faster and more efficiently so that more people can obtain access to better medicine
    Sengenics
    Sengenics is a functional proteomics company that leverages its patented KREXTM technology to discover autoantibody biomarker signatures for the prediction of drug response and severe immune-related adverse events (irAEs). KREX™ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge. Jonathan is the CSO of Sengenics
    United BioPharma
    United BioPharma (UBP) was established in September 2013 as a spinoff company from UBI Asia, taking UBI Asia’s entire monoclonal antibody (mAb) pharmaceutical business, including product rights, technologies, R&D teams, and manufacturing facilities. UBP focuses on developing, manufacturing, and marketing integrated therapeutic mAb products and related technologies. UBP currently has about 90 employees. Among them, 70% are in R&D and 75% have a master’s degree or higher